Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Cancer Research
|
December 24, 2011
Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers
Mounia Beloueche-Babari, Vaitha Arunan, Helen Troy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study
Martine Van Glabbeke, Jaap Verweij, Paolo G Casali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
L Svancárová, J Y Blay, I R Judson, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Richard D Baird, Jos Kitzen, Paul A Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors
Debashis Sarker, Rhoda Molife, T R Jeffrey Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies
Chooi P Lee, Maja J A de Jonge, Anne E O'Donnell, et al.
The Oncologist
|
March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors
Chooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.
Lancet (London, England)
|
October 19, 2006
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D Demetri, Allan T van Oosterom, Christopher R Garrett, et al.
The Lancet. Oncology
|
June 26, 2007
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
Federica Grosso, Robin L Jones, George D Demetri, et al.
British Journal of Cancer
|
June 4, 2014
Dichloroacetate induces autophagy in colorectal cancer cells and tumours
G Lin, D K Hill, G Andrejeva, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Cancer Research
|
December 24, 2011
Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers
Mounia Beloueche-Babari, Vaitha Arunan, Helen Troy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study
Martine Van Glabbeke, Jaap Verweij, Paolo G Casali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
L Svancárová, J Y Blay, I R Judson, et al.
Molecular Cancer Therapeutics
|
June 11, 2009
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Richard D Baird, Jos Kitzen, Paul A Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors
Debashis Sarker, Rhoda Molife, T R Jeffrey Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2006
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies
Chooi P Lee, Maja J A de Jonge, Anne E O'Donnell, et al.
The Oncologist
|
March 22, 2015
Phase I study of nintedanib incorporating dynamic contrast-enhanced magnetic resonance imaging in patients with advanced solid tumors
Chooi Peng Lee, N Jane Taylor, Gerhardt Attard, et al.
Lancet (London, England)
|
October 19, 2006
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D Demetri, Allan T van Oosterom, Christopher R Garrett, et al.
The Lancet. Oncology
|
June 26, 2007
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study
Federica Grosso, Robin L Jones, George D Demetri, et al.
British Journal of Cancer
|
June 4, 2014
Dichloroacetate induces autophagy in colorectal cancer cells and tumours
G Lin, D K Hill, G Andrejeva, et al.
Page
of 14